Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (51-60 of 902) with videos related to

Pageof 91
Sort By:
Blood|February 28, 2020
Overview of Castleman diseaseAngela Dispenzieri, David C Fajgenbaum
Hematological Oncology|June 15, 2025
Non-Clonal Lymphoproliferative DiseasesStefan Dirnhofer, Yoshito Nishimura, Angela Dispenzieri
The Oncologist|March 12, 2026
Limited Discriminatory Performance of the iMCD-IPI in a Western CohortYoshito Nishimura, Thomas Habermann, Angela Dispenzieri
American Journal of Hematology|October 27, 2025
Comparative Safety of Tocilizumab and Siltuximab in Castleman Disease: Pharmacovigilance StudyYoshito Nishimura, Thomas Habermann, Angela Dispenzieri
Hematology/Oncology Clinics of North America|November 22, 2017
POEMS Syndrome: Diagnosis and Investigative Work-upAngela Dispenzieri, Taxiarchis Kourelis, Francis Buadi
Current Opinion in Molecular Therapeutics|January 27, 2009
Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overviewPavlos Msaouel, Angela Dispenzieri, Evanthia Galanis
Heart (British Cardiac Society)|May 1, 2017
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac responseMartha Grogan, Angela Dispenzieri, Morie A Gertz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 6, 2009
Amyloidosis 2008 BMT Tandem Meetings (February 13-17, San Diego)Angela Dispenzieri, Giampaolo Merlini, Raymond L Comenzo
Nature Reviews. Cardiology|October 15, 2014
Pathophysiology and treatment of cardiac amyloidosisMorie A Gertz, Angela Dispenzieri, Taimur Sher
Haematologica|January 21, 2018
Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasoneNelson Leung, Stephan D Thomé, Angela Dispenzieri
Pageof 91

Showing results (51-60 of 902) with videos related to

Sort By:
Pageof 91
Blood|February 28, 2020
Overview of Castleman diseaseAngela Dispenzieri, David C Fajgenbaum
Hematological Oncology|June 15, 2025
Non-Clonal Lymphoproliferative DiseasesStefan Dirnhofer, Yoshito Nishimura, Angela Dispenzieri
The Oncologist|March 12, 2026
Limited Discriminatory Performance of the iMCD-IPI in a Western CohortYoshito Nishimura, Thomas Habermann, Angela Dispenzieri
American Journal of Hematology|October 27, 2025
Comparative Safety of Tocilizumab and Siltuximab in Castleman Disease: Pharmacovigilance StudyYoshito Nishimura, Thomas Habermann, Angela Dispenzieri
Hematology/Oncology Clinics of North America|November 22, 2017
POEMS Syndrome: Diagnosis and Investigative Work-upAngela Dispenzieri, Taxiarchis Kourelis, Francis Buadi
Current Opinion in Molecular Therapeutics|January 27, 2009
Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overviewPavlos Msaouel, Angela Dispenzieri, Evanthia Galanis
Heart (British Cardiac Society)|May 1, 2017
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac responseMartha Grogan, Angela Dispenzieri, Morie A Gertz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 6, 2009
Amyloidosis 2008 BMT Tandem Meetings (February 13-17, San Diego)Angela Dispenzieri, Giampaolo Merlini, Raymond L Comenzo
Nature Reviews. Cardiology|October 15, 2014
Pathophysiology and treatment of cardiac amyloidosisMorie A Gertz, Angela Dispenzieri, Taimur Sher
Haematologica|January 21, 2018
Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasoneNelson Leung, Stephan D Thomé, Angela Dispenzieri
Pageof 91